| ISIN | CH0595227429 | 
|---|---|
| Valor Number | 59522742 | 
| Bloomberg Global ID | VRFSVEC SW | 
| Fund Name | Raiffeisen Futura - Swiss Stock VE | 
| Fund Provider | Raiffeisen Schweiz Genossenschaft, St. Gallen
                                            
    
        St. Gallen, Switzerland Phone: +41 71 225 98 78 E-Mail: fonds@raiffeisen.ch Web: www.raiffeisen.ch | 
| Fund Provider | Raiffeisen Schweiz Genossenschaft, St. Gallen | 
| Representative in Switzerland | Raiffeisen Schweiz Genossenschaft St. Gallen Phone: +41 71 225 98 78 | 
| Distributor(s) | Raiffeisen Schweiz Genossenschaft St. Gallen Phone: +41 71 225 98 78 | 
| Asset Class | Equities | 
| EFC Category | Equity Switzerland | 
| Distribution Policy | Accumulation | 
| Home Country | Switzerland | 
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund | 
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) | 
| Investment Strategy *** | N/A | 
| Peculiarities | 
| Current Price * | 116.82 CHF | 30.10.2025 | 
|---|---|---|
| Previous Price * | 116.31 CHF | 29.10.2025 | 
| 52 Week High * | 120.53 CHF | 13.02.2025 | 
| 52 Week Low * | 101.30 CHF | 09.04.2025 | 
| NAV * | 116.82 CHF | 30.10.2025 | 
| Issue Price * | 116.82 CHF | 30.10.2025 | 
| Redemption Price * | 116.82 CHF | 30.10.2025 | 
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 2,260,614,277 | |
| Unit/Share Assets *** | 609,436,227 | |
| Trading Information SIX | ||
| YTD Performance | +6.18% | 31.12.2024 - 30.10.2025
        31.12.2024 30.10.2025 | 
|---|---|---|
| 1 month | +1.46% | 30.09.2025 - 30.10.2025
        30.09.2025 30.10.2025 | 
| 3 months | -1.52% | 30.07.2025 - 30.10.2025
        30.07.2025 30.10.2025 | 
| 6 months | +1.83% | 30.04.2025 - 30.10.2025
        30.04.2025 30.10.2025 | 
| 1 year | +3.23% | 30.10.2024 - 30.10.2025
        30.10.2024 30.10.2025 | 
| 2 years | +23.49% | 30.10.2023 - 30.10.2025
        30.10.2023 30.10.2025 | 
| 3 years | +22.56% | 31.10.2022 - 30.10.2025
        31.10.2022 30.10.2025 | 
| 5 years | +20.51% | 25.02.2021 - 30.10.2025
        25.02.2021 30.10.2025 | 
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 12.40% | |
|---|---|---|
| Roche Holding AG | 12.06% | |
| ABB Ltd | 4.73% | |
| Zurich Insurance Group AG | 4.24% | |
| Sika AG | 4.07% | |
| Chocoladefabriken Lindt & Spruengli AG Ordinary Shares - Non Voting | 3.71% | |
| Lonza Group Ltd | 3.01% | |
| Swiss Re AG | 2.74% | |
| Alcon Inc | 2.72% | |
| Belimo Holding AG | 2.66% | |
| Last data update | 30.06.2025 | |
| TER | 0.30% | 
|---|---|
| TER date | 31.01.2025 | 
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.40% | 
| Ongoing Charges *** | 0.31% | 
| SRRI *** | |
| SRRI date *** | 30.09.2025 |